Clinical trials · New York, NY
Type 2 diabetes clinical trials in New York
We’re tracking 65 recruiting type 2 diabetes studies with a site in or near New York — including Phase 1/Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT04011020RecruitingPhase 3
Stem cell treatment for type 1 diabetes
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
Paramus, New JerseyAges 10 years+ - NCT07396376RecruitingPhase 1/Phase 2
Testing ELU42 spray for diabetic foot ulcers
This study tests a new topical spray (ELU42) to help heal diabetic foot ulcers. It may be a good option if you have a non-infected, non-ischemic ulcer and your blood sugar is reasonably controlled.
Oradell, New JerseyAges 18–75 - NCT07743307Enrolling by invitation
Diabetes self-management with glucose monitoring
This study tests a program that uses a continuous glucose monitor (CGM), a small sensor that tracks your blood sugar in real time, along with group sessions to help adults with type 2 diabetes better manage their condition. It may help you understand how your daily choices affect your glucose levels.
Manhasset, New YorkAges 18 years+ - NCT05548205Recruiting
Glucose monitoring for people starting insulin after hospital discharge
This study checks whether using a continuous glucose monitor for 2 weeks after you leave the hospital helps you manage blood sugar better when you are newly starting insulin. It may help your care team adjust insulin and track glucose trends more closely right after discharge.
Mineola, New YorkAges 18–100 - NCT07675499RecruitingPhase 2/Phase 3
Exercise and Nasal Insulin for Type 2 Diabetes
This study tests if adding nose spray insulin and exercise together improves blood sugar control and brain function in older adults with type 2 diabetes.
Piscataway, New JerseyAges 55–80 - NCT07784270RecruitingPhase 3
Weight loss injection for adults with type 2 diabetes and overweight
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Warren Township, New JerseyAges 18 years+ - NCT07321886RecruitingPhase 3
Study of eloralintide for people with obesity or overweight
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
Warren Township, New JerseyAges 18 years+ - NCT06663813Recruiting
Preventing diabetes complications for ER patients
This trial offers counseling and support to emergency department patients with high blood sugar to help them adopt healthy habits and prevent diabetes-related problems.
New Brunswick, New JerseyAges 18 years+ - NCT06814184Recruiting
Virtual diabetes care for adults with type 2 diabetes on Medicaid and insulin
This study tests a virtual (remote) diabetes care program for adults with type 2 diabetes who are on insulin and have Medicaid insurance. It aims to help improve blood sugar control using a smartphone app or text messages.
New Brunswick, New JerseyAges 18–90 - NCT07197788Enrolling by invitation
Continued access to the Endogenex device study for type 2 diabetes
This trial offers continued access to the Endogenex system for people who were in the sham (placebo) group of the ReCET study and have completed their 12-month visit. It tests a device that treats the duodenum to improve blood sugar control.
New Brunswick, New JerseyAges 22 years+ - NCT06546085Recruiting
Extracellular vesicles, insulin, and exercise in type 2 diabetes
This study looks at how tiny particles called extracellular vesicles affect how your body uses insulin, and whether exercise can make a difference. It is for people with type 2 diabetes (or normal blood sugar) who are not very active and have been on diabetes medication for a long time.
New Brunswick, New JerseyAges 30–80 - NCT05785780Enrolling by invitation
Help improve colon cancer screening for people with diabetes
This study looks for better ways to make sure people with diabetes get up-to-date colon cancer screening. If you haven’t had the recommended test on time, it may help identify barriers in primary care and improve screening follow-through.
New Brunswick, New JerseyAges 50–74 - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Somerset, New JerseyAges 18 years+ - NCT07612475Enrolling by invitation
Universal type 1 diabetes screening in children
This study helps clinics add a simple blood test to well-child visits to catch type 1 diabetes early, before symptoms appear. It also asks parents and clinic staff for feedback to make screening easier and more routine.
Commack, New YorkAges 1 year+ - NCT07684144RecruitingPhase 3
Long-term study of a weight-loss medication for people who completed an earlier trial
This study tests the long-term effects of a medication called maridebart cafraglutide for weight management. It is for people who already completed a 72-week study of this drug and want to continue treatment.
Trenton, New JerseyAges 18–99 - NCT07662044RecruitingPhase 3
Studying elecoglipron for type 2 diabetes
This trial tests a new medicine called elecoglipron, taken alone or with another diabetes drug (dapagliflozin), to see if it helps control blood sugar better than a placebo. It may be an option if your current treatment isn't working well enough.
Bridgeport, ConnecticutAges 18 years+ - NCT07662213RecruitingPhase 3
Elecoglipron vs semaglutide for type 2 diabetes
This study tests an experimental diabetes pill (elecoglipron) to see if it works as well as a current medicine, semaglutide, for people with type 2 diabetes who also have heart risk factors. It aims to help better control blood sugar and weight.
Bridgeport, ConnecticutAges 18 years+
Hear when a new Type 2 diabetes trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Type 2 diabetes trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting type 2 diabetes studies listed above.
- Research Site · 4 studies
- Institute for Food, Nutrition, and Health · 2 studies
- Robert Wood Johnson University Hospital Clinical Research Center · 2 studies
- Rutgers University Loree Gymnasium · 2 studies
- Center for Advanced Human Brain Imaging Research
- Curalta Clinical Trials
- IMA Clinical Research Warren
- Northwell Heath
What taking part in a type 2 diabetes study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting type 2 diabetes studies in New York.
Common questions
- Are there type 2 diabetes clinical trials near New York?
- Yes. We're currently tracking 65 recruiting type 2 diabetes studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a type 2 diabetes study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New type 2 diabetes studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.